Search Results Search Sort by RelevanceMost Recent Policy Forum May 2003 The Virtue of Drawing Lines in Genetic Testing Rosemarie Tong, PhD Virtual Mentor. 2003;5(5):143-145. doi: 10.1001/virtualmentor.2003.5.5.pfor1-0305. Original Research Mar 2018 Structural Competency and Reproductive Health Margaret Mary Downey, MSW and Anu Manchikanti Gómez, MSc, PhD AMA J Ethics. 2018;20(3):211-223. doi: 10.1001/journalofethics.2018.20.3.peer1-1803. State of the Art and Science Nov 2002 Adopting the Unborn Swathi Arekapudi Virtual Mentor. 2002;4(11):331-333. doi: 10.1001/virtualmentor.2002.4.11.gnth1-0211. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Case and Commentary Jan 2021 How Should a Physician Respond to Discovering Her Patient Has Been Forcibly Sterilized? Rebecca Kluchin, PhD Sterilization requires physicians’ surgical skills. Forced sterilization requires many clinicians’ complicity. AMA J Ethics. 2021;23(1):E18-25. doi: 10.1001/amajethics.2021.18. Case and Commentary Jan 2022 Should Dentists Treat Despite Medical Contraindications? Bernard Friedland, BChD, MSc, JD Some patients who need general medical care before a dental intervention can suffer increased risk for poor outcomes if they have compromised access to care. AMA J Ethics. 2022;24(1):E6-12. doi: 10.1001/amajethics.2022.6. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858. Policy Forum Dec 2020 What Should We Do About the Mismatch Between Legal Criteria for Death and How Brain Death Is Diagnosed? Nathaniel M. Robbins, MD and James L. Bernat, MD Criteria in statutes and tests used to diagnose brain death don’t always jibe, and this can undermine public trust in death pronouncements. AMA J Ethics. 2020;22(12):E1038-1046. doi: 10.1001/amajethics.2020.1038.